Allergies News and Research

Latest Allergies News and Research

Home visits, mobile clinics do not improve asthma outcomes in children

A new Johns Hopkins Children's Center study of Baltimore City children with asthma shows that two programs designed to improve disease outcomes among those who may be affected the worst fall short of expectations.

30 Nov 2011

Counterparts of memory cells ward off microbial foes

The immune system possesses a type of cell that can be activated by tissues within the body to remind the immune system not to attack our own molecules, cells and organs, UCSF researchers have discovered.

29 Nov 2011

UIC recruiting volunteers for study on effectiveness of vitamin D in addition to asthma medication

Researchers at the University of Illinois at Chicago are recruiting volunteers with asthma for a study of whether taking vitamin D can make asthma medication more effective.

29 Nov 2011

Daily inhaled steroids comparable to use of intermittent steroid treatment for wheezing

Pediatricians often treat young children who have frequent bouts of wheezing with a daily dose of an inhaled steroid to keep asthma symptoms at bay. But results of a recent study are likely to change that.

29 Nov 2011

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

VOICE, an HIV prevention trial that has been evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women - daily use of one of two different ARV tablets or of a vaginal gel - has stopped testing the gel.

29 Nov 2011

Tenofovir gel no more effective than placebo gel in preventing HIV

An independent review of the VOICE study, funded by the National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the Microbicide Trials Network, determined that tenofovir gel was no more effective than placebo gel in preventing HIV.

28 Nov 2011

Ansell purchases minority share of Yulex

Ansell Limited, a global leader in protection solutions, today announced it has purchased a minority share of Yulex Corporation, a manufacturer of biopolymers derived from guayule.

28 Nov 2011

Laminar air flow therapy via novel device could be beneficial for asthmatics: Study

A new device that offers drug-free bedside filtered air flow can significantly reduce patients' symptoms such as wheezing and tight chests in asthmatics. The temperature controlled laminar airflow treatment, called Protexo, filters out airborne triggers such as dust particles and mites, pet hairs and powders that cause irritation and inflammation of the lungs.

27 Nov 2011

NIH-led study advances HIV vaccine research

HIV is coated in sugars that usually hide the virus from the immune system. Newly published research reveals how one broadly neutralizing HIV antibody actually uses part of the sugary cloak to help bind to the virus. The antibody binding site, called the V1/V2 region, represents a suitable HIV vaccine target, according to the scientists who conducted the study. In addition, their research reveals the detailed structure of the V1/V2 region, the last part of the virus surface to be visualized at the atomic level.

24 Nov 2011

Nocturnal temperature controlled laminar airflow treatment for atopic asthma

A simple device that filters out airborne asthma triggers during sleep can ease persistent symptoms of the condition during the day and improve quality of life, suggests research published online in Thorax.

24 Nov 2011

Eating fish before age of nine months reduces risk of pre-school wheeze in children

Children who started eating fish before nine months of age are less likely to suffer from pre-school wheeze, but face a higher risk if they were treated with broad spectrum antibiotics in the first week of life or their mother took paracetamol during pregnancy.

22 Nov 2011

Titanium particles from artificial joints may play a direct role in painful inflammation

Many people with painful, creaky knees and hips find relief after replacing their bad joints with new artificial joints made from titanium. But some of these people develop painful inflammation that can lead to bone destruction and loosening of the new joint. A new study led by researchers at the University of Medicine and Dentistry of New Jersey and published by the Journal of Immunology suggests that tiny titanium particles that flake away from the artificial joints through normal wear and tear may play a direct role in that inflammation.

22 Nov 2011

HRR1 after 6MW test is a strong predictor of clinical worsening in IPAH patients

Heart rate recovery at one minute after a six-minute walking distance (6MWD) test is highly predictive of clinical worsening and time to clinical worsening in patients with idiopathic pulmonary arterial hypertension (IPAH), according to a new study.

19 Nov 2011

EUSA Pharma receives FDA approval for Erwinaze to treat ALL

The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.

18 Nov 2011

ACAAI president available to comment on School Access to Emergency Epinephrine Act

Dr. Stanley Fineman, president of the American College of Allergy, Asthma and Immunology, (ACAAI) is available to comment on the School Access to Emergency Epinephrine Act, a federal bill introduced today that will help make epinephrine available in schools for the immediate treatment of anaphylactic reactions to food or other allergens.

18 Nov 2011

Researchers discover new class of antimalarial compounds

Researchers have discovered a group of chemical compounds that might one day be developed into drugs that can treat malaria infection in both the liver and the bloodstream.

18 Nov 2011

InDevR introduces ampliPHOX system for microbiological analysis

InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.

18 Nov 2011

Flu strains migrate back and forth between different regions of the world

Influenza researchers have found that flu strains migrate back and forth between different regions of the world, evolving along the way. This is contrary to the common belief that flu strains from the tropics are the source of global seasonal epidemics.

17 Nov 2011

WSU researchers to study novel antibiotic that may treat VRE infection

The bacteria Enterococcus can cause infections that typically target the digestive tract or bowel; if the bacteria spread, an abdominal abscess or urinary infection could result. Enterococcus also can invade the bloodstream, leading to meningitis, pneumonia or endocarditis - an infection of the heart valve.

17 Nov 2011

NIAID's ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases' (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.

16 Nov 2011

Allergies News and Research

Latest Allergies News and Research

Home visits, mobile clinics do not improve asthma outcomes in children

Counterparts of memory cells ward off microbial foes

UIC recruiting volunteers for study on effectiveness of vitamin D in addition to asthma medication

Daily inhaled steroids comparable to use of intermittent steroid treatment for wheezing

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

Tenofovir gel no more effective than placebo gel in preventing HIV

Ansell purchases minority share of Yulex

Laminar air flow therapy via novel device could be beneficial for asthmatics: Study

NIH-led study advances HIV vaccine research

Nocturnal temperature controlled laminar airflow treatment for atopic asthma

Eating fish before age of nine months reduces risk of pre-school wheeze in children

Titanium particles from artificial joints may play a direct role in painful inflammation

HRR1 after 6MW test is a strong predictor of clinical worsening in IPAH patients

EUSA Pharma receives FDA approval for Erwinaze to treat ALL

ACAAI president available to comment on School Access to Emergency Epinephrine Act

Researchers discover new class of antimalarial compounds

InDevR introduces ampliPHOX system for microbiological analysis

Flu strains migrate back and forth between different regions of the world

WSU researchers to study novel antibiotic that may treat VRE infection

NIAID's ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Allergies News and Research

Latest Allergies News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in